These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26087183)

  • 1. F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression.
    Tian X; Dai S; Sun J; Jin G; Jiang S; Meng F; Li Y; Wu D; Jiang Y
    Oncotarget; 2015 Sep; 6(26):22767-75. PubMed ID: 26087183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
    Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma.
    Li Q; Gao Y; Jia Z; Mishra L; Guo K; Li Z; Le X; Wei D; Huang S; Xie K
    Gastroenterology; 2012 Sep; 143(3):799-810.e2. PubMed ID: 22677193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F-Box Protein FBXO22 Mediates Polyubiquitination and Degradation of CD147 to Reverse Cisplatin Resistance of Tumor Cells.
    Wu B; Liu ZY; Cui J; Yang XM; Jing L; Zhou Y; Chen ZN; Jiang JL
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBXO22 mediates polyubiquitination and inactivation of LKB1 to promote lung cancer cell growth.
    Zhu XN; He P; Zhang L; Yang S; Zhang HL; Zhu D; Liu MD; Yu Y
    Cell Death Dis; 2019 Jun; 10(7):486. PubMed ID: 31217475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCF
    Bai J; Wu K; Cao MH; Yang Y; Pan Y; Liu H; He Y; Itahana Y; Huang L; Zheng JN; Pan ZQ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11754-11763. PubMed ID: 31138683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of FBXO22 inhibits melanoma cell migration, invasion and angiogenesis via the HIF-1α/VEGF pathway.
    Zheng Y; Chen H; Zhao Y; Zhang X; Liu J; Pan Y; Bai J; Zhang H
    Invest New Drugs; 2020 Feb; 38(1):20-28. PubMed ID: 30887251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of Krüppel-like factor-4 by microRNA-135a-5p promotes proliferation and metastasis in hepatocellular carcinoma by transforming growth factor-β1.
    Yao S; Tian C; Ding Y; Ye Q; Gao Y; Yang N; Li Q
    Oncotarget; 2016 Jul; 7(27):42566-42578. PubMed ID: 27302923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis.
    Guo F; Liu J; Han X; Zhang X; Lin T; Wang Y; Bai J; Han J
    Int J Biol Sci; 2019; 15(3):647-656. PubMed ID: 30745851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.
    Sun H; Peng Z; Tang H; Xie D; Jia Z; Zhong L; Zhao S; Ma Z; Gao Y; Zeng L; Luo R; Xie K
    Oncogene; 2017 May; 36(21):2957-2968. PubMed ID: 28192402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
    Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
    Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence.
    Johmura Y; Sun J; Kitagawa K; Nakanishi K; Kuno T; Naiki-Ito A; Sawada Y; Miyamoto T; Okabe A; Aburatani H; Li S; Miyoshi I; Takahashi S; Kitagawa M; Nakanishi M
    Nat Commun; 2016 Feb; 7():10574. PubMed ID: 26868148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
    Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
    Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression.
    Sun R; Xie HY; Qian JX; Huang YN; Yang F; Zhang FL; Shao ZM; Li DQ
    Cancer Res; 2018 Sep; 78(18):5274-5286. PubMed ID: 29945959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression.
    Sun J; Wang B; Liu Y; Zhang L; Ma A; Yang Z; Ji Y; Liu Y
    Cancer Lett; 2014 Dec; 355(1):25-33. PubMed ID: 25242357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FBXO22, an epigenetic multiplayer coordinating senescence, hormone signaling, and metastasis.
    Johmura Y; Harris AS; Ohta T; Nakanishi M
    Cancer Sci; 2020 Aug; 111(8):2718-2725. PubMed ID: 32536008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLF4 Suppresses the Progression of Hepatocellular Carcinoma by Reducing Tumor ATP Synthesis through Targeting the Mir-206/RICTOR Axis.
    Wang Y; Zuo D; Huang Z; Qiu Y; Wu Z; Liu S; Zeng Y; Qiu Z; He W; Li B; Yuan Y; Niu Y; Qiu J
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Krüppel-like factor 4 modulates the migration and invasion of hepatoma cells by suppressing TIMP-1 and TIMP-2.
    Sung MT; Hsu HT; Lee CC; Lee HC; Kuo YJ; Hua K; Hsia CY; Chi CW
    Oncol Rep; 2015 Jul; 34(1):439-46. PubMed ID: 25954999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBXO22 Mediates the NGF/TRKA Signaling Pathway in Bone Metastases in Prostate Cancer.
    Zhang Y; Li W; Guo S; Wu Z; Zhang L; Liu Y; Li X; Guo X; Cao J; Yang C; Wang Z
    Am J Pathol; 2023 Sep; 193(9):1248-1266. PubMed ID: 37301536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAF7 enhances ubiquitin-degradation of KLF4 to promote hepatocellular carcinoma progression.
    He H; Wu Z; Li S; Chen K; Wang D; Zou H; Chen H; Li Y; Liu Z; Qu C
    Cancer Lett; 2020 Jan; 469():380-389. PubMed ID: 31730901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.